v3.25.2
Segment Information - Schedule of Segment Loss (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting Information [Line Items]        
Total operating expenses $ 17,061 $ 19,391 $ 34,402 $ 36,274
Loss from operations (17,061) (19,391) (34,402) (36,274)
Net loss (15,675) (16,976) (31,433) (32,406)
Operating Segments        
Segment Reporting Information [Line Items]        
Facilities related expense 2,400 652 4,699 1,304
Stock-based compensation and depreciation 2,010 2,401 4,124 3,991
Total operating expenses 17,061 19,391 34,402 36,274
Loss from operations (17,061) (19,391) (34,402) (36,274)
Interest and other income, net 1,386 2,415 2,969 3,868
Net loss (15,675) (16,976) (31,433) (32,406)
Research and Development | Operating Segments        
Segment Reporting Information [Line Items]        
Compensation and benefits expenses [1] 3,217 3,679 6,512 7,165
Clinical trial costs 2,448 2,935 5,298 5,532
Outsourced services and Consulting 3,132 5,363 5,514 10,042
Lab and pharmacology supplies 256 695 546 1,399
Other costs [2] 440 465 1,036 898
General and Administrative Expenses | Operating Segments        
Segment Reporting Information [Line Items]        
Compensation and benefits expenses [1] 1,528 1,645 3,102 3,192
Professional service fees 810 748 1,807 1,541
Insurance 202 213 420 243
Other Costs [3] $ 618 $ 595 $ 1,344 $ 967
[1] Excludes stock-based compensation expense.
[2] Includes software expense, database subscriptions expense, lab service contract expense, travel expense, and other miscellaneous expenses.
[3] Includes travel expense, public & investor relations expense, software expense, employee training & development expense, and other miscellaneous expenses.